Medical Device Apps: An Introduction to Regulatory Affairs for Developers

Abstract

The Poly Implant Prothèse (PIP) scandal in France prompted a revision of the regulations regarding the marketing of medical devices. The new Medical Device Regulation (MDR [EU]) 2017/745 was developed and entered into force on May 25, 2017. After a transition period of 3 years, the regulations must be implemented in all EU and European Economic Area member states. The implementation of this regulation bears many changes for medical device development and marketing, including medical device software and mobile apps. Medical device development and marketing is a complex process by which manufacturers must keep many regulatory requirements and obligations in mind. The objective of this paper is to provide an introduction and overview of regulatory affairs for manufacturers that are new to the field of medical device software and apps with a specific focus on the new MDR, accompanying harmonized standards, and guidance documents from the European Commission. This work provides a concise overview of the qualification and classification of medical device software and apps, conformity assessment routes, technical documentation, clinical evaluation, the involvement of notified bodies, and the unique device identifier. Compared to the previous Medical Device Directive (MDD) 93/42/EEC, the MDR provides greater detail about the requirements for software qualification and classification. In particular, rule 11 sets specific rules for the classification of medical device software and will be described in this paper. In comparison to the previous MDD, the MDR is more stringent, especially regarding the classification of health apps and software. The implementation of the MDR in May 2020 and its interpretation by the authorities will demonstrate how app and software manufacturers as well as patients will be affected by the regulation.

Future Mobile Device Usage, Requirements, and Expectations of Physicians in German University Hospitals: Web-Based Survey

“…The development of medical software such as mobile apps, especially those subject to new European Medical Device Regulation 2017/745, is a complex process including many obligations and requirements for manufacturers [ 43 ]. In addition to the regulatory legal requirements of the European Medical Device Regulation, health care professionals ask for the certification of health care apps [ 44 ].…”

Using Medical Device Standards for Design and Risk Management of Immersive Virtual Reality for At-Home Therapy and Remote Patient Monitoring

“…Numerous reports have examined challenges and best practices for introducing medical device regulatory requirements, such as design controls and risk management, into contemporary software development practices such as Agile [39,40,[100][101][102][103][104][105][106][107][108][109][110].…”

Assessment of mHealth Interventions: Need for New Studies, Methods, and Guidelines for Study Designs

“…In recent years, cumulative knowledge has been gathered on the risks associated with poor usability of health IT [ 7 ]. In line with this literature, a step forward was taken only for mHealth solutions, which are qualified as medical devices [ 8 ]. However, even for those applications, national and international regulations (ie, CE marking in Europe or FDA regulations) and harmonized standards (ie, EN 62366 advised for CE marking in Europe) strengthened the requirements for premarket certifications but did not standardize a threshold for usability or technical performance.…”